Contact Us
Site Map
Quick Links
Management
Board of Directors
Novel Platform
Clinical Programs
SITEMAP
Home
About Us
BOARD OF DIRECTORS
MANAGEMENT
Novel Platform
SAFETY
EFFICACY
TECHNOLOGY PLATFORM
Product Candidates
PRODUCT PIPELINE
VT-111 (SERINE PROTEASE INHIBITOR)
VT-346 (TNF-α BINDING PROTEIN)
VT-384 (IL-18 BINDING PROTEIN)
VT-214 (CHEMOKINE BINDING PROTEIN)
VT-310 (IL-10 HOMOLOGUE)
VT-362 (CD-30 HOMOLOGUE)
DISCOVERY
Partnerships
Investors
INQUIRIES
OVERVIEW
Media Room
Viron granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates
Viron Reports Positive Phase II Data in Acute Coronary Syndromes (ACS) Patients
Viron to Present Data from Phase II Trial at American Heart Association Conference
Careers
CAREER OPPORTUNITIES
PRIVACY POLICY
CONTACT US
Webdesign Ruhrgebiet